CONTEXT:  Commercial announcement of an RWE tie up with a major pharma company tying up with an RWE provider to generate “high validity” observational studies.  Interesting phrase, that we are likely to see more and more as RWE grows in popularity.

IMPACT:  Medium

READ TIME:  1 min

Quality Level Mean [1 – 10]:  6


1. “PALO ALTO, Calif., March 18, 2021 /PRNewswire/ — Verantos announced today a collaboration with Amgen to launch an advanced real-world evidence (RWE) program focused on high-validity observational studies.” 

2. “We partnered with Verantos based on their demonstrated expertise in real-world data curation and RWE creation.”” 

3. “Advanced RWE studies incorporate deep phenotyping from electronic health records, leveraging rich narrative data and artificial intelligence.” 

4. “The Verantos RWE platform integrates heterogenous real world data sources and generates evidence with the accuracy necessary for regulatory and reimbursement use.” 

5. “The Verantos RWE platform leverages data science and artificial intelligence along with advanced data sources such as electronic health records (EHR) to generate RWE capable of supporting clinical assertions.” 
Source URL: https://www.prnewswire.com/news-releases/verantos-announces-new-agreement-in-advanced-real-world-evidence-301250464.html